Beranda › Kanker Payudara › California › Baldwin Park
Uji klinis Kanker Payudara di Baldwin Park, CA
44 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Menerima pesertaFase 3
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Menerima pesertaFase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi jauhnya
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Menerima pesertaFase 3
- City of Hope National Medical, Duarte · 4 mi jauhnya
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Menerima pesertaFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Menerima pesertaFase 1
- Research Site, Duarte · 4 mi jauhnya
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- City of Hope, Duarte · 4 mi jauhnya
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Menerima pesertaFase 1/2
- City of Hope - Duarte, Duarte · 4 mi jauhnya
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Menerima pesertaFase 3
- Research Site, Duarte · 4 mi jauhnya
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Menerima pesertaFase 2
- City of Hope--Duarte, Duarte · 4 mi jauhnya
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Menerima peserta
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Menerima pesertaFase 3
- City of Hope - Duarte Cancer Center, Duarte · 4 mi jauhnya
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi jauhnya
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Menerima pesertaFase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Menerima pesertaFase 4
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Menerima pesertaFase 3
- City of Hope Medical Center, Duarte · 4 mi jauhnya
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- City of Hope, Duarte · 4 mi jauhnya
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Beckman Research Institute of City of Hope, Duarte · 4 mi jauhnya
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope, Duarte · 4 mi jauhnya
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Menerima pesertaSukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauhnya
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Menerima pesertaFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Baldwin Park
- Leukemia Mieloid Akut40 studi
- Kanker Kolorektal37 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)34 studi
- Kanker Prostat30 studi
- Kanker Metastatik30 studi
- Sindrom Mielodisplastik26 studi
- Kanker Ovarium25 studi
- Kanker Paru24 studi
- Mieloma Multipel23 studi
- Kanker Lambung22 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.